| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.19 | 8e-05 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.094 | 0.05 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.081 | 0.09 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.077 | 0.09 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.068 | 0.1 |